TipRanks on MSN
TG Therapeutics’ New Study on Ublituximab: A Potential Game-Changer for Pediatric MS Treatment
TG Therapeutics (($TGTX)) announced an update on their ongoing clinical study. The clinical study titled ‘Ublituximab in Pediatric Participants ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback